Global Chronic Heart Failure Treatment Market Size, Status and Forecast 2024-2031

Report ID: 921472 | Published Date: Jan 2025 | No. of Page: 125 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Heart Failure Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 ICDs
        1.2.3 VADs
        1.2.4 Drugs
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Chronic Heart Failure Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Household
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chronic Heart Failure Treatment Market Perspective (2016-2027)
    2.2 Chronic Heart Failure Treatment Growth Trends by Regions
        2.2.1 Chronic Heart Failure Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chronic Heart Failure Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Chronic Heart Failure Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Chronic Heart Failure Treatment Industry Dynamic
        2.3.1 Chronic Heart Failure Treatment Market Trends
        2.3.2 Chronic Heart Failure Treatment Market Drivers
        2.3.3 Chronic Heart Failure Treatment Market Challenges
        2.3.4 Chronic Heart Failure Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chronic Heart Failure Treatment Players by Revenue
        3.1.1 Global Top Chronic Heart Failure Treatment Players by Revenue (2016-2021)
        3.1.2 Global Chronic Heart Failure Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Chronic Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chronic Heart Failure Treatment Revenue
    3.4 Global Chronic Heart Failure Treatment Market Concentration Ratio
        3.4.1 Global Chronic Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Heart Failure Treatment Revenue in 2020
    3.5 Chronic Heart Failure Treatment Key Players Head office and Area Served
    3.6 Key Players Chronic Heart Failure Treatment Product Solution and Service
    3.7 Date of Enter into Chronic Heart Failure Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Heart Failure Treatment Breakdown Data by Type
    4.1 Global Chronic Heart Failure Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Heart Failure Treatment Breakdown Data by Application
    5.1 Global Chronic Heart Failure Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chronic Heart Failure Treatment Market Size (2016-2027)
    6.2 North America Chronic Heart Failure Treatment Market Size by Type
        6.2.1 North America Chronic Heart Failure Treatment Market Size by Type (2016-2021)
        6.2.2 North America Chronic Heart Failure Treatment Market Size by Type (2022-2027)
        6.2.3 North America Chronic Heart Failure Treatment Market Size by Type (2016-2027)
    6.3 North America Chronic Heart Failure Treatment Market Size by Application
        6.3.1 North America Chronic Heart Failure Treatment Market Size by Application (2016-2021)
        6.3.2 North America Chronic Heart Failure Treatment Market Size by Application (2022-2027)
        6.3.3 North America Chronic Heart Failure Treatment Market Size by Application (2016-2027)
    6.4 North America Chronic Heart Failure Treatment Market Size by Country
        6.4.1 North America Chronic Heart Failure Treatment Market Size by Country (2016-2021)
        6.4.2 North America Chronic Heart Failure Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chronic Heart Failure Treatment Market Size (2016-2027)
    7.2 Europe Chronic Heart Failure Treatment Market Size by Type
        7.2.1 Europe Chronic Heart Failure Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Chronic Heart Failure Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Chronic Heart Failure Treatment Market Size by Type (2016-2027)
    7.3 Europe Chronic Heart Failure Treatment Market Size by Application
        7.3.1 Europe Chronic Heart Failure Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Chronic Heart Failure Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Chronic Heart Failure Treatment Market Size by Application (2016-2027)
    7.4 Europe Chronic Heart Failure Treatment Market Size by Country
        7.4.1 Europe Chronic Heart Failure Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Chronic Heart Failure Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Heart Failure Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Chronic Heart Failure Treatment Market Size by Type
        8.2.1 Asia-Pacific Chronic Heart Failure Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chronic Heart Failure Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Application
        8.3.1 Asia-Pacific Chronic Heart Failure Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chronic Heart Failure Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chronic Heart Failure Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region
        8.4.1 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chronic Heart Failure Treatment Market Size (2016-2027)
    9.2 Latin America Chronic Heart Failure Treatment Market Size by Type
        9.2.1 Latin America Chronic Heart Failure Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Chronic Heart Failure Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Chronic Heart Failure Treatment Market Size by Type (2016-2027)
    9.3 Latin America Chronic Heart Failure Treatment Market Size by Application
        9.3.1 Latin America Chronic Heart Failure Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Chronic Heart Failure Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Chronic Heart Failure Treatment Market Size by Application (2016-2027)
    9.4 Latin America Chronic Heart Failure Treatment Market Size by Country
        9.4.1 Latin America Chronic Heart Failure Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Chronic Heart Failure Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Heart Failure Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Chronic Heart Failure Treatment Market Size by Type
        10.2.1 Middle East & Africa Chronic Heart Failure Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chronic Heart Failure Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Application
        10.3.1 Middle East & Africa Chronic Heart Failure Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chronic Heart Failure Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chronic Heart Failure Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country
        10.4.1 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Medtronic
        11.1.1 Medtronic Company Details
        11.1.2 Medtronic Business Overview
        11.1.3 Medtronic Chronic Heart Failure Treatment Introduction
        11.1.4 Medtronic Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.1.5 Medtronic Recent Development
    11.2 Abbott
        11.2.1 Abbott Company Details
        11.2.2 Abbott Business Overview
        11.2.3 Abbott Chronic Heart Failure Treatment Introduction
        11.2.4 Abbott Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.2.5 Abbott Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Details
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Chronic Heart Failure Treatment Introduction
        11.3.4 Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Chronic Heart Failure Treatment Introduction
        11.4.4 Merck Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.4.5 Merck Recent Development
    11.5 Stanley Pharmaceuticals
        11.5.1 Stanley Pharmaceuticals Company Details
        11.5.2 Stanley Pharmaceuticals Business Overview
        11.5.3 Stanley Pharmaceuticals Chronic Heart Failure Treatment Introduction
        11.5.4 Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.5.5 Stanley Pharmaceuticals Recent Development
    11.6 New Haven Pharmaceuticals, Inc.
        11.6.1 New Haven Pharmaceuticals, Inc. Company Details
        11.6.2 New Haven Pharmaceuticals, Inc. Business Overview
        11.6.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Introduction
        11.6.4 New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.6.5 New Haven Pharmaceuticals, Inc. Recent Development
    11.7 Boston Scientific Corporation
        11.7.1 Boston Scientific Corporation Company Details
        11.7.2 Boston Scientific Corporation Business Overview
        11.7.3 Boston Scientific Corporation Chronic Heart Failure Treatment Introduction
        11.7.4 Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.7.5 Boston Scientific Corporation Recent Development
    11.8 HeartWare
        11.8.1 HeartWare Company Details
        11.8.2 HeartWare Business Overview
        11.8.3 HeartWare Chronic Heart Failure Treatment Introduction
        11.8.4 HeartWare Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.8.5 HeartWare Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Chronic Heart Failure Treatment Introduction
        11.9.4 Pfizer Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.9.5 Pfizer Recent Development
    11.10 GlaxoSmithKline plc
        11.10.1 GlaxoSmithKline plc Company Details
        11.10.2 GlaxoSmithKline plc Business Overview
        11.10.3 GlaxoSmithKline plc Chronic Heart Failure Treatment Introduction
        11.10.4 GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.10.5 GlaxoSmithKline plc Recent Development
    11.11 Novartis International AG
        11.11.1 Novartis International AG Company Details
        11.11.2 Novartis International AG Business Overview
        11.11.3 Novartis International AG Chronic Heart Failure Treatment Introduction
        11.11.4 Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.11.5 Novartis International AG Recent Development
    11.12 Biovail Corporation
        11.12.1 Biovail Corporation Company Details
        11.12.2 Biovail Corporation Business Overview
        11.12.3 Biovail Corporation Chronic Heart Failure Treatment Introduction
        11.12.4 Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.12.5 Biovail Corporation Recent Development
    11.13 Bristol-Myers Squibb Company
        11.13.1 Bristol-Myers Squibb Company Company Details
        11.13.2 Bristol-Myers Squibb Company Business Overview
        11.13.3 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Introduction
        11.13.4 Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.13.5 Bristol-Myers Squibb Company Recent Development
    11.14 Abiomed
        11.14.1 Abiomed Company Details
        11.14.2 Abiomed Business Overview
        11.14.3 Abiomed Chronic Heart Failure Treatment Introduction
        11.14.4 Abiomed Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.14.5 Abiomed Recent Development
    11.15 Symplmed Pharmaceuticals
        11.15.1 Symplmed Pharmaceuticals Company Details
        11.15.2 Symplmed Pharmaceuticals Business Overview
        11.15.3 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Introduction
        11.15.4 Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.15.5 Symplmed Pharmaceuticals Recent Development
    11.16 Berlin Heart GmbH
        11.16.1 Berlin Heart GmbH Company Details
        11.16.2 Berlin Heart GmbH Business Overview
        11.16.3 Berlin Heart GmbH Chronic Heart Failure Treatment Introduction
        11.16.4 Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.16.5 Berlin Heart GmbH Recent Development
    11.17 ReliantHeart, Inc.
        11.17.1 ReliantHeart, Inc. Company Details
        11.17.2 ReliantHeart, Inc. Business Overview
        11.17.3 ReliantHeart, Inc. Chronic Heart Failure Treatment Introduction
        11.17.4 ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.17.5 ReliantHeart, Inc. Recent Development
    11.18 Cardiokinetix
        11.18.1 Cardiokinetix Company Details
        11.18.2 Cardiokinetix Business Overview
        11.18.3 Cardiokinetix Chronic Heart Failure Treatment Introduction
        11.18.4 Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.18.5 Cardiokinetix Recent Development
    11.18 Biotronik
        .1 Biotronik Company Details
        .2 Biotronik Business Overview
        .3 Biotronik Chronic Heart Failure Treatment Introduction
        .4 Biotronik Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        .5 Biotronik Recent Development
    11.20 Jarvik Heart
        11.20.1 Jarvik Heart Company Details
        11.20.2 Jarvik Heart Business Overview
        11.20.3 Jarvik Heart Chronic Heart Failure Treatment Introduction
        11.20.4 Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2016-2021)
        11.20.5 Jarvik Heart Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chronic Heart Failure Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of ICDs
    Table 3. Key Players of VADs
    Table 4. Key Players of Drugs
    Table 5. Key Players of Others
    Table 6. Global Chronic Heart Failure Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Chronic Heart Failure Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Chronic Heart Failure Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Chronic Heart Failure Treatment Market Share by Regions (2016-2021)
    Table 10. Global Chronic Heart Failure Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Chronic Heart Failure Treatment Market Share by Regions (2022-2027)
    Table 12. Chronic Heart Failure Treatment Market Trends
    Table 13. Chronic Heart Failure Treatment Market Drivers
    Table 14. Chronic Heart Failure Treatment Market Challenges
    Table 15. Chronic Heart Failure Treatment Market Restraints
    Table 16. Global Chronic Heart Failure Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Chronic Heart Failure Treatment Market Share by Players (2016-2021)
    Table 18. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Heart Failure Treatment as of 2020)
    Table 19. Ranking of Global Top Chronic Heart Failure Treatment Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Chronic Heart Failure Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Chronic Heart Failure Treatment Product Solution and Service
    Table 23. Date of Enter into Chronic Heart Failure Treatment Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2016-2021)
    Table 27. Global Chronic Heart Failure Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Chronic Heart Failure Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2016-2021)
    Table 31. Global Chronic Heart Failure Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Chronic Heart Failure Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Chronic Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Chronic Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Chronic Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Chronic Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Chronic Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Chronic Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Chronic Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Chronic Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Chronic Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Chronic Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Chronic Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Chronic Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Chronic Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Chronic Heart Failure Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Chronic Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Chronic Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Chronic Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Chronic Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Chronic Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Chronic Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Chronic Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Chronic Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Chronic Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Chronic Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Medtronic Company Details
    Table 64. Medtronic Business Overview
    Table 65. Medtronic Chronic Heart Failure Treatment Product
    Table 66. Medtronic Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 67. Medtronic Recent Development
    Table 68. Abbott Company Details
    Table 69. Abbott Business Overview
    Table 70. Abbott Chronic Heart Failure Treatment Product
    Table 71. Abbott Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 72. Abbott Recent Development
    Table 73. Johnson & Johnson Company Details
    Table 74. Johnson & Johnson Business Overview
    Table 75. Johnson & Johnson Chronic Heart Failure Treatment Product
    Table 76. Johnson & Johnson Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 77. Johnson & Johnson Recent Development
    Table 78. Merck Company Details
    Table 79. Merck Business Overview
    Table 80. Merck Chronic Heart Failure Treatment Product
    Table 81. Merck Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 82. Merck Recent Development
    Table 83. Stanley Pharmaceuticals Company Details
    Table 84. Stanley Pharmaceuticals Business Overview
    Table 85. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product
    Table 86. Stanley Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 87. Stanley Pharmaceuticals Recent Development
    Table 88. New Haven Pharmaceuticals, Inc. Company Details
    Table 89. New Haven Pharmaceuticals, Inc. Business Overview
    Table 90. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product
    Table 91. New Haven Pharmaceuticals, Inc. Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 92. New Haven Pharmaceuticals, Inc. Recent Development
    Table 93. Boston Scientific Corporation Company Details
    Table 94. Boston Scientific Corporation Business Overview
    Table 95. Boston Scientific Corporation Chronic Heart Failure Treatment Product
    Table 96. Boston Scientific Corporation Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 97. Boston Scientific Corporation Recent Development
    Table 98. HeartWare Company Details
    Table 99. HeartWare Business Overview
    Table 100. HeartWare Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 101. HeartWare Recent Development
    Table 102. Pfizer Company Details
    Table 103. Pfizer Business Overview
    Table 104. Pfizer Chronic Heart Failure Treatment Product
    Table 105. Pfizer Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 106. Pfizer Recent Development
    Table 107. GlaxoSmithKline plc Company Details
    Table 108. GlaxoSmithKline plc Business Overview
    Table 109. GlaxoSmithKline plc Chronic Heart Failure Treatment Product
    Table 110. GlaxoSmithKline plc Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 111. GlaxoSmithKline plc Recent Development
    Table 112. Novartis International AG Company Details
    Table 113. Novartis International AG Business Overview
    Table 114. Novartis International AG Chronic Heart Failure Treatment Product
    Table 115. Novartis International AG Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 116. Novartis International AG Recent Development
    Table 117. Biovail Corporation Company Details
    Table 118. Biovail Corporation Business Overview
    Table 119. Biovail Corporation Chronic Heart Failure Treatment Product
    Table 120. Biovail Corporation Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 121. Biovail Corporation Recent Development
    Table 122. Bristol-Myers Squibb Company Company Details
    Table 123. Bristol-Myers Squibb Company Business Overview
    Table 124. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product
    Table 125. Bristol-Myers Squibb Company Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 126. Bristol-Myers Squibb Company Recent Development
    Table 127. Abiomed Company Details
    Table 128. Abiomed Business Overview
    Table 129. Abiomed Chronic Heart Failure Treatment Product
    Table 130. Abiomed Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 131. Abiomed Recent Development
    Table 132. Symplmed Pharmaceuticals Company Details
    Table 133. Symplmed Pharmaceuticals Business Overview
    Table 134. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product
    Table 135. Symplmed Pharmaceuticals Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 136. Symplmed Pharmaceuticals Recent Development
    Table 137. Berlin Heart GmbH Company Details
    Table 138. Berlin Heart GmbH Business Overview
    Table 139. Berlin Heart GmbH Chronic Heart Failure Treatment Product
    Table 140. Berlin Heart GmbH Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 141. Berlin Heart GmbH Recent Development
    Table 142. ReliantHeart, Inc. Company Details
    Table 143. ReliantHeart, Inc. Business Overview
    Table 144. ReliantHeart, Inc. Chronic Heart Failure Treatment Product
    Table 145. ReliantHeart, Inc. Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 146. ReliantHeart, Inc. Recent Development
    Table 147. Cardiokinetix Company Details
    Table 148. Cardiokinetix Business Overview
    Table 149. Cardiokinetix Chronic Heart Failure Treatment Product
    Table 150. Cardiokinetix Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 151. Cardiokinetix Recent Development
    Table 152. Biotronik Company Details
    Table 153. Biotronik Business Overview
    Table 154. Biotronik Chronic Heart Failure Treatment Product
    Table 155. Biotronik Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 156. Biotronik Recent Development
    Table 157. Jarvik Heart Company Details
    Table 158. Jarvik Heart Business Overview
    Table 159. Jarvik Heart Chronic Heart Failure Treatment Product
    Table 160. Jarvik Heart Revenue in Chronic Heart Failure Treatment Business (2016-2021) & (US$ Million)
    Table 161. Jarvik Heart Recent Development
    Table 162. Research Programs/Design for This Report
    Table 163. Key Data Information from Secondary Sources
    Table 164. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Heart Failure Treatment Market Share by Type: 2020 VS 2027
    Figure 2. ICDs Features
    Figure 3. VADs Features
    Figure 4. Drugs Features
    Figure 5. Others Features
    Figure 6. Global Chronic Heart Failure Treatment Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Household Case Studies
    Figure 10. Others Case Studies
    Figure 11. Chronic Heart Failure Treatment Report Years Considered
    Figure 12. Global Chronic Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Chronic Heart Failure Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Chronic Heart Failure Treatment Market Share by Regions: 2020 VS 2027
    Figure 15. Global Chronic Heart Failure Treatment Market Share by Regions (2022-2027)
    Figure 16. Global Chronic Heart Failure Treatment Market Share by Players in 2020
    Figure 17. Global Top Chronic Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Heart Failure Treatment as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Chronic Heart Failure Treatment Revenue in 2020
    Figure 19. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2016-2021)
    Figure 20. Global Chronic Heart Failure Treatment Revenue Market Share by Type (2022-2027)
    Figure 21. North America Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Chronic Heart Failure Treatment Market Share by Type (2016-2027)
    Figure 23. North America Chronic Heart Failure Treatment Market Share by Application (2016-2027)
    Figure 24. North America Chronic Heart Failure Treatment Market Share by Country (2016-2027)
    Figure 25. United States Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Chronic Heart Failure Treatment Market Share by Type (2016-2027)
    Figure 29. Europe Chronic Heart Failure Treatment Market Share by Application (2016-2027)
    Figure 30. Europe Chronic Heart Failure Treatment Market Share by Country (2016-2027)
    Figure 31. Germany Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Chronic Heart Failure Treatment Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Chronic Heart Failure Treatment Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Chronic Heart Failure Treatment Market Share by Region (2016-2027)
    Figure 41. China Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Chronic Heart Failure Treatment Market Share by Type (2016-2027)
    Figure 49. Latin America Chronic Heart Failure Treatment Market Share by Application (2016-2027)
    Figure 50. Latin America Chronic Heart Failure Treatment Market Share by Country (2016-2027)
    Figure 51. Mexico Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Chronic Heart Failure Treatment Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Chronic Heart Failure Treatment Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Chronic Heart Failure Treatment Market Share by Country (2016-2027)
    Figure 57. Turkey Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Chronic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Medtronic Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 61. Abbott Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 62. Johnson & Johnson Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 63. Merck Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 64. Stanley Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 65. New Haven Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 66. Boston Scientific Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 67. HeartWare Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 68. Pfizer Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 69. GlaxoSmithKline plc Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 70. Novartis International AG Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 71. Biovail Corporation Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 72. Bristol-Myers Squibb Company Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 73. Abiomed Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 74. Symplmed Pharmaceuticals Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 75. Berlin Heart GmbH Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 76. ReliantHeart, Inc. Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 77. Cardiokinetix Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 78. Biotronik Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 79. Jarvik Heart Revenue Growth Rate in Chronic Heart Failure Treatment Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Medtronic
Abbott
Johnson & Johnson
Merck
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Pfizer
GlaxoSmithKline plc
Novartis International AG
Biovail Corporation
Bristol-Myers Squibb Company
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Frequently Asked Questions
Chronic Heart Failure Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Heart Failure Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Heart Failure Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports